Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Exchange Rate Effect came in at $448000.0 in Q1 2026, up 22500.0% year-on-year from N/an in Q1 2025, and up 600.0% on a QoQ basis from $64000.0 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 4 years of Exchange Rate Effect data on file, last reported at $448000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 22500.0% year-over-year to $448000.0 in Q1 2026; TTM through Mar 2026 was $537000.0, a 656.34% increase from a year earlier, with the FY2025 full-year figure at $87000.0, up 4250.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $448000.0, up from $64000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for RYTM reached as high as $977000.0 in Q4 2024 and fell as low as -$603000.0 in Q3 2024.
- Historically, Exchange Rate Effect has averaged $30384.6 across 4 years, with a median of -$2000.0 in 2025.
- Across the five-year window, Exchange Rate Effect sank 883.12% in 2024 and surged 22500.0% in 2026, its largest moves.
- Year by year, Exchange Rate Effect stood at -$192000.0 in 2023, then surged by 608.85% to $977000.0 in 2024, then tumbled by 93.45% to $64000.0 in 2025, then jumped by 600.0% to $448000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $448000.0 in Q1 2026, $64000.0 in Q4 2025, and $304000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.99 Bn | 6.64 Bn | 52.96 Mn | 448,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 448,000.00 |
| Mar 31, 2026 | 448,000.00 |
| Dec 31, 2025 | 64,000.00 |
| Dec 31, 2025 | 64,000.00 |
| Sep 30, 2025 | 304,000.00 |
| Sep 30, 2025 | 304,000.00 |
| Jun 30, 2025 | -279,000.00 |
| Jun 30, 2025 | -279,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Dec 31, 2024 | 977,000.00 |
| Dec 31, 2024 | 977,000.00 |
| Sep 30, 2024 | -603,000.00 |
| Sep 30, 2024 | -603,000.00 |
| Jun 30, 2024 | -301,000.00 |
| Jun 30, 2024 | -301,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Mar 31, 2024 | -71,000.00 |
| Dec 31, 2023 | -192,000.00 |
| Dec 31, 2023 | -192,000.00 |